Recently diagnosed with HIV? Click here

HIV prevention

Displayed below is content from the NAPWA website tagged with the keyword HIV prevention.

New hope for vaccine

Positive Living article • Adrian Ogier • 26 May 2011

Melbourne university researchers have identified antibodies in a breakthrough that brings closer the hope of developing an effective vaccine.

A study of 100 people with HIV, recruitedThe act of signing up participants into a study. Generally this process involves evaluating a participant with respect to the eligibility criteria of the study and going through the informed consentThe process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. process. from The Alfred Hospital and the Melbourne Sexual Health Centre, has shown that antibodies were so successful in suppressing the virusA small infective organism which is incapable of reproducing outside a host cell. that it had to mutate around them. read more »

Treatment reduces transmission risk

Positive Living article • Adrian Ogier • 26 May 2011
HIV prevention

We have known for some time that HAARTHighly Active AntiRetroviralA medication or other substance which is active against retroviruses such as HIV. Therapy ??? aggressive treatment of HIV infection using several different drugs together. reduces the likelihood of transmitting HIV, and the recent results from a large clinical trialA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. seem to confirm the fact . . . in heterosexual couples, at least. read more »

HIV treatments as prevention findings welcomed by people living with HIV

Media release • 13 May 2011

Today’s announcement that a clinical trialA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. has found that HIV antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment significantly reduces the risk of HIV transmission is welcome news, the National Association of People Living with HIV/AIDS (NAPWHA) has said. read more »

What's Your Problem?

Positive Living article • Dr Louise Owen • 25 February 2011

Doctor Louise answers readers' questions. In this issue she discusses Hepatitis C infection and unprotected sex. read more »

Wrapped or Raw - Positive Life NSW

Video • Paul Kidd • 26 November 2010

‘WRAPPED OR RAW’ looks at choices made by pos guys about using condoms in pos-pos sex and offers information and options to minimise risk (like STIs[Sexually Transmissible (or Transmitted) Infection] Infections spread by the transfer of organisms from person to person during sexual contact. Also called venereal disease (VD) (an older public health term) or sexually transmitted diseases (STDs). – sexually transmissible infections) and have great sex.

For further information, visit http://www.wrappedorraw.org.au/watch video »

Microbicides, PrEP and treatment as prevention

Positive Living article • Paul Kidd • 2 September 2010
HIV prevention

Significant advances in HIV prevention were unveiled at the XVIII International AIDS Conference in Vienna, with research advancing on several fronts towards new prevention technologies. Paul Kidd reports. read more »

AIDS 2010: microbicide breakthrough

Story • Paul Kidd • 21 July 2010

In what is being called a major breakthrough, a trial of a vaginal microbicide gel in South African women has shown for the first time that such a product can be effective against HIV infection. read more »

Serodiscordant study

Positive Living article • Adrian Ogier • 11 June 2010
living with HIV

While it has long been acknowledged that successful antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment and an undetectable viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. lowers the risk of passing on HIV, we have little research to support the fact. read more »

Address to the Australasian HIV/AIDS Conference

Story • Robert Mitchell • 9 September 2009

“HIV prevention must be supported from an evidence base of best health promotion practice and with respect for the rights and dignity of those living with HIV,” NAPWHA president Robert Mitchell has told today’s opening ceremony of the 21st Australasian HIV/AIDS Conference. read more »

Give your vagina a choice

Positive Living article • Adrian Ogier • 20 August 2009

If you know nothing about them, you're not alone. At a recent leadership forum held in Sydney by UNIFEM Australia only five out of the 100 young women present had even heard of the female condom. Adrian Ogier finds out more. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWHA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWHA's work and be alerted to new content on the website by following @napwa.

Join us on Facebook NAPWHA Facebook.

Find out more at LinkedIn

Find out more about NAPWHA at LinkedInNAPWHA at LinkedIn.